Skip to main content

Posters

Showing 1 of 4

New

Real-World Outcomes After 2 Years of Dupilumab Therapy for Severe Asthma: The ProVENT Study

Confidential. For use by Medical Affairs for scientific exchange purposes only. Do not copy or distribute. Some information may not be consistent with the approved product labelling for the product(s) being discussed; this information may relate to the indication or use, dosage and administration, patient population, combination use, or other potential unapproved uses. No conclusions regarding safety and efficacy can be made for such uses.